Literature DB >> 11107173

Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability.

K Shitoh1, T Furukawa, M Kojima, F Konishi, M Miyaki, T Tsukamoto, H Nagai.   

Abstract

It has been reported that wild-type APC protein forms a complex with beta-Catenin and GSK3beta, inducing degradation of beta-Catenin in normal cells. Both beta-Catenin and APC gene mutations have recently been shown to activate the same signaling pathway. Frequent mutations of beta-Catenin in hereditary nonpolyposis colorectal carcinomas have also been reported. It was, however, controversial whether the mutation of the beta-Catenin gene was frequent in nonfamilial colorectal carcinomas with high-frequency microsatellite instability (MSI-H). We analyzed the mutations of the APC and beta-Catenin genes in 56 nonfamilial colorectal carcinomas stratified according to the presence or absence of microsatellite instability (MSI). APC mutations were identified in 11 of 22 (50%) cases of MSI-H and 14 of 34 (41%) cases of microsatellite-stable (MSS)/low-frequency microsatellite instability (MSI-L). In contrast, the frequency of beta-Catenin mutations was significantly higher in MSI-H (6/22; 27%) than in MSS/MSI-L (1/34; 3%) (P = 0.01). beta-Catenin mutations were not detected in carcinomas with APC mutation. APC mutation occurred irrespective of MSI status. beta-Catenin mutation, however, occurred frequently in MSI-H carcinomas. Our data suggest that activation of the beta-Catenin-Tcf signaling pathway, through either beta-Catenin or APC mutation, frequently contributes to MSI-H nonfamilial colorectal carcinomas (17/22; 77%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11107173     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1065>3.0.co;2-i

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

Review 1.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

2.  Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.

Authors:  B H Park; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.

Authors:  V Johnson; E Volikos; S E Halford; E T Eftekhar Sadat; S Popat; I Talbot; K Truninger; J Martin; J Jass; R Houlston; W Atkin; I P M Tomlinson; A R J Silver
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

4.  Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.

Authors:  Amira Salah El-Din Youssef; Mohamed A Abdel-Fattah; Mai M Lotfy; Auhood Nassar; Mohamed Abouelhoda; Ahmed O Touny; Zeinab K Hassan; Mohammed Mohey Eldin; Abeer A Bahnassy; Hussein Khaled; Abdel Rahman N Zekri
Journal:  Curr Issues Mol Biol       Date:  2022-03-18       Impact factor: 2.976

5.  Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

Authors:  Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Reiko Dehari; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

6.  Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.

Authors:  Silvio K Scheel; Marc Porzner; Sabine Pfeiffer; Steffen Ormanns; Thomas Kirchner; Andreas Jung
Journal:  BMC Cancer       Date:  2010-08-09       Impact factor: 4.430

7.  Germline EPHB2 receptor variants in familial colorectal cancer.

Authors:  George Zogopoulos; Claus Jorgensen; Julinor Bacani; Alexandre Montpetit; Pierre Lepage; Vincent Ferretti; Lauren Chad; Subani Selvarajah; Brent Zanke; Thomas J Hudson; Tony Pawson; Steven Gallinger
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

8.  Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.

Authors:  Alireza Tabibzadeh; Fahimeh Safarnezhad Tameshkel; Yousef Moradi; Saber Soltani; Maziar Moradi-Lakeh; G Hossein Ashrafi; Nima Motamed; Farhad Zamani; Seyed Abbas Motevalian; Mahshid Panahi; Maryam Esghaei; Hossein Ajdarkosh; Alireza Mousavi-Jarrahi; Mohammad Hadi Karbalaie Niya
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

9.  The majority of β-catenin mutations in colorectal cancer is homozygous.

Authors:  Alexander Arnold; Moritz Tronser; Christine Sers; Aysel Ahadova; Volker Endris; Soulafa Mamlouk; David Horst; Markus Möbs; Philip Bischoff; Matthias Kloor; Hendrik Bläker
Journal:  BMC Cancer       Date:  2020-10-28       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.